<DOC>
	<DOCNO>NCT00395031</DOCNO>
	<brief_summary>The aim protocol study effect 320 mg/day ziprasidone ( Geodon ) glucose lipid metabolism patient Diabetes Type II ( DM ) schizophrenia schizoaffective disorder , switch antipsychotic medication/s typical and/or atypical ziprasidone monotherapy .</brief_summary>
	<brief_title>Effect Ziprasidone Glucose &amp; Plasma Lipids Diabetes ( II ) Schizophrenia Schizoaffective Disorder</brief_title>
	<detailed_description>Inpatients DSM IV diagnosis schizophrenia schizoaffective disorder DM II enrol give informed consent . Participants may stay original ward MPC , clinical care would better serve home ward patient program and/or continuity care reason . Patients recruit participate site transfer MPC research ward . There screen phase ( two week ) prior antipsychotic regimen , cross-titration phase ( three week ) ziprasidone phase ( eight week ; four time point ) . All medication , except antipsychotic agent , keep stable throughout protocol . These medication may include anticholinergic , mood stabilizer antidepressant . After screen phase last two week , patient enter cross-titration phase last three week . The cross titration schedule change accordance Deutschman &amp; Deutschman 's 2005 recommendation . The current antipsychotic gradually decrease zero ziprasidone start 40 mg bid po raise 160 mg po bid cross-titration phase , accord clinical response tolerance . After cross-titration phase conclude , ziprasidone dose range 80 mg bid p.o . 160 mg bid p.o . daily accord clinical response eight week treatment phase .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Ziprasidone</mesh_term>
	<criteria>1 . Aged 18 65 year 2 . DSM IV diagnosis schizophrenia ( subtypes ) schizoaffective disorder 3 . Diabetes Mellitus type II treat oral antidiabetic drug insulin 4 . Stable dose antipsychotic regimen previous one month . 5 . Stable dose antidepressant regimen previous one month . 6 . Stable dose adjunctive mood stabilizer and/or anticholinergic regimen previous 1 month 7 . Signed informed consent 8 . Absence significant cardiovascular pathology demonstrate EKG ( QTc &lt; 450 millisec ) 9 . Absence severe medical condition ( except DM ) require frequent change medication . 1 . DSM IV diagnosis Schizophrenia Schizoaffective disorder 2 . Unstable epilepsy 3 . Acute , unstable significant medical condition 4 . Suicidal physically violent behavioral episode previous month 5 . Current DSM IV diagnosis substance alcohol abuse positive urine toxicology past two week . 6 . Liver enzyme test value ≥ three time upper normal limit AST , ALT , GGT , Alkaline Phosphatase ; ≥ two time upper limit LDH .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>schizophrenia</keyword>
	<keyword>Schizoaffective Disorder</keyword>
	<keyword>metabolic marker</keyword>
	<keyword>ziprasidone</keyword>
	<keyword>diabetes</keyword>
</DOC>